D. Medical Industries (DMED)
D. Medical Industries Debt to Equity Ratio: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
DMED Debt to Equity Ratio Rankings
| Overall | 99th percentile | 1 of 4260 |
| Sector | 99th percentile | 1 of 477 in Healthcare |
| Industry | 98th percentile | 1 of 64 in Medical Instruments & Supplies |
DMED Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.00 | Jun 2010 |
| Maximum | 0.00 | Jun 2010 |
| Average | 0.00 |
About Debt to Equity Ratio
YCharts Calculation: Debt to Equity = (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity
The debt to equity ratio is a leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. It reveals how a company has financed its assets. A low debt to equity ratio indicates lower risk because shareholder's have claims on a larger portion of the company's assets.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
You may also be interested in these DMED related companies
DMED News
D. Medical (DMED) Enters into OEM Agreement for Spring Universal DDI Sets
May 14, 7:48AM Street Insider
May 14, 7:48AM Street Insider
D. Medical Signs First Worldwide OEM Agreement for Spring Universal(TM) Detach Detect Infusion Sets
May 14, 7:45AM GlobeNewswire
May 14, 7:45AM GlobeNewswire
D. Medical Announces Availability of Its Annual Report on Form 20-F Through Its Website
Apr 30, 2:15PM GlobeNewswire
Apr 30, 2:15PM GlobeNewswire
D. Medical (DMED) Initiates Strategic Restructuring; Will Reduce Staff, Executive Compensation
Mar 22, 7:47AM Street Insider
Mar 22, 7:47AM Street Insider
D. Medical Receives NASDAQ Notification of Non-Compliance With Minimum Bid Price Rule
Mar 13, 10:45AM GlobeNewswire
Mar 13, 10:45AM GlobeNewswire
D. Medical Makes Strategic Changes to Its European Distribution Network for Its Spring Universal Infusion Sets
Feb 14, 8:15AM GlobeNewswire
Feb 14, 8:15AM GlobeNewswire
D. Medical Signs Fifth U.S. Distribution Agreement for Spring Universal Infusion Sets
Jan 25, 8:03AM Benzinga
Jan 25, 8:03AM Benzinga
Expansion of D. Medical's U.S. Distribution Network for Spring Universal Infusion Sets Continues
Jan 17, 8:10AM GlobeNewswire
Jan 17, 8:10AM GlobeNewswire
Spring Universal Infusion Set Listed in the 2012 Consumer Guide of the American Diabetes Association
Jan 04, 8:30AM GlobeNewswire
Jan 04, 8:30AM GlobeNewswire
Instructional Video Now Available for Evolutionary Spring Universal Infusion Set
Dec 26, 7:57AM GlobeNewswire
Dec 26, 7:57AM GlobeNewswire
D. Medical Further Expands U.S. Distribution Network for Spring Universal Infusion Sets
Dec 05, 7:45AM GlobeNewswire
Dec 05, 7:45AM GlobeNewswire
A 3-Year Supply of Spring Universal Infusion Set to be Donated to an Uninsured Family
Nov 13, 8:01AM GlobeNewswire
Nov 13, 8:01AM GlobeNewswire
D. Medical expands U.S. distribution network for Spring Universal infusion sets
Oct 06, 8:16AM FlyOnTheWall
Oct 06, 8:16AM FlyOnTheWall
D. Medical Initiates Strategic Restructuring; Includes Contemplated Staff Reduction
Sep 07, 9:32AM Benzinga
Sep 07, 9:32AM Benzinga
D. Medical to Present at the Rodman & Renshaw Annual Global Investment Conference
Sep 02, 9:07AM Marketwire
Sep 02, 9:07AM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DMED | 0.38 | +0.00 | +0.00% | 4.108M |
| DMD | 9.67 | +0.05 | +0.52% | 806.38M |
| DM | 6.84 | -0.03 | -0.44% | 209.17M |
| DLX | 22.88 | -0.10 | -0.44% | 1.165B |
| DLTR | 102.20 | +0.49 | +0.48% | 11.82B |
| DLS | 43.55 | -0.11 | -0.25% | |
| DLN | 50.66 | -0.11 | -0.22% | |
| DLLR | 15.52 | -0.03 | -0.19% | 684.90M |
| DIS | 44.50 | +0.06 | +0.14% | 79.76B |
| DIOD | 19.61 | +0.20 | +1.03% | 891.47M |
